Evidence map›Paper›PMID 41028096›Full record

ArticleScientific reports2025

Modelling the dynamically consistent numerical methods for COVID-19 disease with cost effectiveness strategies.

Shuo Li, Muhammad Amjad Abbas, Ihsan Ullah Khan, Ali Akgül, Ali G Alkhathami, Murad Khan Hassani

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuo LiSchool of Mathematics and Data Sciences, Changji University, Changji, 831100, Xinjiang, China.
Muhammad Amjad AbbasDepartment of Mathematics, Institute of Numerical Sciences, Gomal University, Dera Ismail Khan, 29050, KPK, Pakistan.
Ihsan Ullah KhanDepartment of Mathematics, Institute of Numerical Sciences, Gomal University, Dera Ismail Khan, 29050, KPK, Pakistan.
Ali AkgülDepartment of Electronics and Communication Engineering, Saveetha School of Engineering, SIMATS, Chennai, Tamilnadu, India.
Ali G AlkhathamiDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
Murad Khan HassaniDepartment of Mathematics, Ghazni University, Ghazni, Afghanistan. mhassani@gu.edu.af.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, a perilous disease triggered by the SARS-CoV-2 virus, exhibits an unusually high spread rate through both direct and indirect physical contact. There are many ways to inspect the possibility of COVID-19 which may include but not limited to shortness of breath, fatigue, strict headaches, tastelessness, continuous chest pain, diarrhea and vomiting. In the present paper, the COVID-19 deterministic mathematical model with cost effectiveness strategies is considered and examined. The threshold quantity, assisting in establishing the existence and stability characteristics of equilibria, is computed by employing the next-generation matrix. The main objective of the present work is to use conditionally stable Euler and Runge-Kutta of order 4 (RK-4) schemes with the collaboration of unconditionally stable non-standard finite difference (NSFD) scheme to show the changing behavior of consistent SEIHR epidemic model. The Euler and RK-4 schemes are unable to precisely focus on the important aspects of the continuous model, resulting in numerical solutions that are not entirely analogous to the original model. However, the NSFD scheme provides a straightforward approach that demonstrates how discrete and continuous models behave appropriately and yield mathematically precise results. The NSFD system is a useful tool for tracking the spread of COVID-19 disease. For the NSFD scheme, different criteria and theories are employed to discuss the local and global stability of disease-free and endemic equilibria. Numerical simulations are provided to verify the theoretical findings and validate the dynamical aspects of the aforementioned schemes.

Indexed as

Cost-Benefit AnalysisCOVID-19Models, TheoreticalCost-Effectiveness AnalysisHumansPandemicsSARS-CoV-2COVID-19 modelLocal and global stabilityNumerical schemesReproduction numberRouth-Hurwitz criterionSchur-Cohn criterion

Identifiers

PMID41028096
PMCPMC12485142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.